FTC sues main pharmacy benefit managers around insulin charges The company brought motion towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the checklist cost of daily life-preserving insulin medicines. Insurers will continue vertically integrating to keep much more profits in-residence, and federal https://kethek.com/